Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
Penel N, Bui BN, Bay JO, Cupissol D, Ray-Coquard I, Piperno-Neumann S, Kerbrat P, Fournier C, Taieb S, Jimenez M, Isambert N, Peyrade F, Chevreau C, Bompas E, Brain EG, Blay JY.
J Clin Oncol. 2008 Nov 10;26(32):5269-74. doi: 10.1200/JCO.2008.17.3146. Epub 2008 Sep 22.
Masticator space: CT and MRI of secondary tumor spread.
Wei Y, Xiao J, Zou L.
AJR Am J Roentgenol. 2007 Aug;189(2):488-97. doi: 10.2214/AJR.07.2212.
Nephrogenic epistaxis.
Kumar R, Sikka K, Kumar R, Chatterjee P.
Singapore Med J. 2014 Jul;55(7):e112-3. doi: 10.11622/smedj.2013185.
Sentinel lymph node biopsy in malignant melanoma of the head and neck.
Rahimi-Nedjat RK, Al-Nawas B, Tuettenberg A, Sagheb K, Grabbe S, Walter C.
J Craniomaxillofac Surg. 2018 Jun;46(6):1027-1031. doi: 10.1016/j.jcms.2018.04.011. Epub 2018 Apr 12.
Malignant melanoma of the skin of the head and neck. An analysis of 405 cases.
Ballantyne AJ.
Am J Surg. 1970 Oct;120(4):425-31. doi: 10.1016/s0002-9610(70)80001-0.
Squamoid eccrine ductal carcinoma.
Jacob J, Kugelman L.
Cutis. 2018 May;101(5):378;380;385.
Intraoral reconstructive techniques.
Wells MD, Edwards AL, Luce EA.
Clin Plast Surg. 1995 Jan;22(1):91-108.
Functional anatomy of lymphatic vessels under the aspect of tumor invasion.
Duenne AA, Werner JA.
Recent Results Cancer Res. 2000;157:82-9. doi: 10.1007/978-3-642-57151-0_7.
Liposarcomas of the head and neck: a review of the literature and addition of four cases.
Saunders JR, Jaques DA, Casterline PF, Percarpio B, Goodloe S Jr.
Cancer. 1979 Jan;43(1):162-8. doi: 10.1002/1097-0142(197901)43:1<162::aid-cncr2820430124>3.0.co;2-2.
Significance of P-53 antigen in malignant melanomas and naevi of the head and neck area.
Korabiowska M, Brinck U, Hoenig JF, Bartkowski SB, Kellner S, Marx D, Schauer A.
Anticancer Res. 1995 May-Jun;15(3):885-9.
